Siegfried Holding AG (SWX:SFZN)

Market Cap	4.01B
Revenue (ttm)	1.29B
Net Income (ttm)	160.06M
Shares Out	4.38M
EPS (ttm)	36.88
PE Ratio	24.84
Forward PE	23.44
Dividend	3.80 (0.43%)
Ex-Dividend Date	Apr 22, 2025

Volume	779
Average Volume	10,654
Open	917.00
Previous Close	916.00
Day's Range	902.00 - 917.00
52-Week Range	537.00 - 1,188.00
Beta	0.72
RSI	56.39
Earnings Date	Aug 21, 2025

About Siegfried Holding AG

Siegfried Holding AG, together with its subsidiaries, engages in contract development and manufacturing of active pharmaceutical ingredient (API) and finished dosage forms worldwide. The company offers drug substances, including exclusive synthesis that manufactures custom APIs. It also offers an API portfolio, including non-exclusive APIs and pharma-grade substances that focus on anesthetics, pain and addiction treatment applications, and central nervous and respiratory diseases, as well as caffeine for human health and nutrition. In addition,...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1873
• Employees: 3,886
• Stock Exchange: SIX Swiss Exchange
• Ticker Symbol: SFZN

Financial Performance

In 2024, Siegfried Holding AG's revenue was 1.29 billion, an increase of 1.82% compared to the previous year's 1.27 billion. Earnings were 160.06 million, an increase of 41.93%.